No black box warning on record for Iopidine 1%

As of the latest FDA labeling reviewed, Iopidine 1% (APRACLONIDINE HYDROCHLORIDE OPHTHALMIC SOLUTION) does not carry a black box warning. Standard warnings and precautions still apply — see the full Iopidine 1% medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS FOR TOPICAL OPHTHALMIC USE ONLY. Not for injection or oral ingestion. Topical administration of apraclonidine have been reported to cause cardiovascular collapse requiring intubation and ventilation in pediatric patients 6 years and younger, including neonates. Systemic adverse reactions such as prolonged lethargy and unresponsiveness, apnea, hypoxia, respiratory failure, bradycardia, hyp

No black box warning on record for Iopidine 1%

Other warnings & precautions

WARNINGS FOR TOPICAL OPHTHALMIC USE ONLY. Not for injection or oral ingestion. Topical administration of apraclonidine have been reported to cause cardiovascular collapse requiring intubation and ventilation in pediatric patients 6 years and younger, including neonates. Systemic adverse reactions such as prolonged lethargy and unresponsiveness, apnea, hypoxia, respiratory failure, bradycardia, hyp

Iopidine 1% Black Box Warning

No black box warning on record for Iopidine 1%

Other warnings & precautions

Iopidine 1% Black Box Warning

No black box warning on record for Iopidine 1%

Other warnings & precautions